Skip to main content
Clinical Trials/NCT04894396
NCT04894396
Completed
Not Applicable

A Randomised Control Trial Comparing Prefabricated Orthotics With and Without Metatarsal Pad in Decreasing Pain and Fear of Falling in Older Adults

Talita Cumi Ltd.1 site in 1 country206 target enrollmentJuly 23, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Foot Pain
Sponsor
Talita Cumi Ltd.
Enrollment
206
Locations
1
Primary Endpoint
Changes in pain as assessed by a Visual Analogue Scale (VAS)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

To investigate and compare the use of a prefabricated Orthotic, with and without a metatarsal pad in decreasing pain and fear of falling in older adults.

Detailed Description

It is estimated that around 24% of community-dwelling adults over the age of 45 experience frequent foot pain. Falls and fear of falling are also significant issues in this population as both can result in avoidance of activities and decreased physical performance. In cases where fear of falling decreases physical performance and increases activity avoidance, it actually becomes a risk factor for falling itself. Previous studies have shown that various types of Orthotic insoles improve balance and reduce lower-extremity pain in older adults. However, research which directly compares the effects of two different types of insoles is limited. Hence, this randomised control trial will investigate and compare the use of a prefabricated Orthotic, with and without a metatarsal pad, in decreasing pain and fear of falling in older adults. This randomised control trial will be conducted over a 6-week period. The study population will include 206 participants who will be randomised into 2 groups (Group A and Group B). Participants in Group A will receive an Orthotic with a metatarsal pad and participants in Group B will receive a neutral Orthotic without the metatarsal pad. All participants will be required to continue with usual activities, using the Orthotic wherever possible for a period of 6 weeks. Participants will be asked to provide data in the form of completed surveys twice, once at the study onset and once at the end.

Registry
clinicaltrials.gov
Start Date
July 23, 2021
End Date
January 15, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A least 60 years of age
  • Live in a community-based setting
  • Are capable of ambulation
  • Have some form of self-identified foot pain

Exclusion Criteria

  • Compromised skin integrity of the lower limbs
  • Peripheral neuropathy and lack of sensation in the feet.
  • Previous history of foot surgery and
  • Inability to follow the instructions and procedures of the research protocol.

Outcomes

Primary Outcomes

Changes in pain as assessed by a Visual Analogue Scale (VAS)

Time Frame: Baseline and 6 weeks

Pain scores will be collected using the Visual Analogue Scale (VAS) as follows: Levels of pain on a 0 to 10 scale with 0 representing no pain, 2 - mild pain, 5 - moderate pain, 7 - severe pain, and 10 represents extremely severe pain. Utilization of this scale is in line with previous research \[and will measure pain in the feet, ankles, knees, hips, and lower back.

Secondary Outcomes

  • Changes in foot pain & functionality as assessed by the Foot Health Status Questionnaire (FHSQ)(Baseline and 6 weeks)
  • Fear of falling as assessed by the Falls Efficacy Scale International (FES-I) short.(Baseline and 6 weeks)

Study Sites (1)

Loading locations...

Similar Trials